An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome
- PMID: 19215335
- DOI: 10.1111/j.1440-1746.2008.05740.x
An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome
Abstract
Objectives: The aim of this study was to determine if there is an association between non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). NAFLD and PCOS are both known to be associated with metabolic syndrome/insulin resistance.
Method: Fourteen consecutive female patients of reproductive age (20-45) either with liver biopsy proven NAFLD (50%) or abdominal ultrasound (US) consistent with steatosis together with elevated ALT levels (50%) were screened for PCOS using 2003 Rotterdam consensus meeting criteria. Other causes of hyperandrogenism were excluded. All subjects underwent relevant questionnaire and clinical exam together with hormonal assays, pelvic (1) or transvaginal US (13) and were screened for evidence of the metabolic syndrome.
Results: Ten out of fourteen women matched 2003 Rotterdam consensus meeting diagnostic criteria for PCOS (71%). Eight women suffered from oligo/amenorrhoea, nine women manifested presence of hyperandrogenism and six had history of infertility. Seven women had evidence of biochemical hyperandrogenism with low SHBG, raised free testosterone and elevation of serum LH concentration. Seven women fulfilled US criteria for PCOS. Three of ten patients with PCOS also had type 2 diabetes mellitus. Women with PCOS and NAFLD had higher triglyceride and cholesterol and lower HDL level than group without PCOS. Five patients with NAFLD and PCOS had documented fibrosis on liver biopsy, indicative of more advanced liver disease.
Implications: Despite limitations of the study due to the sample size, we found evidence of PCOS in the majority of subjects with NAFLD. Women with NAFLD should be routinely screened for presence of PCOS, diabetes mellitus and metabolic risk factors for cardiovascular disease. Equally, women with PCOS should be screened for NAFLD. Evaluation for liver disease should be considered at an earlier age in some women with PCOS particularly those with an evidence of metabolic syndrome.
Similar articles
-
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.Hum Reprod. 2010 Jan;25(1):212-20. doi: 10.1093/humrep/dep380. Epub 2009 Nov 3. Hum Reprod. 2010. PMID: 19887498
-
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12. Arch Gynecol Obstet. 2006. PMID: 16691383
-
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.Clin Gastroenterol Hepatol. 2007 Apr;5(4):496-501. doi: 10.1016/j.cgh.2006.10.010. Epub 2007 Feb 6. Clin Gastroenterol Hepatol. 2007. PMID: 17287148
-
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.Ann N Y Acad Sci. 2006 Dec;1092:158-74. doi: 10.1196/annals.1365.014. Ann N Y Acad Sci. 2006. PMID: 17308142 Review.
-
Type 2 diabetes and the polycystic ovary syndrome.Minerva Ginecol. 2004 Feb;56(1):41-51. Minerva Ginecol. 2004. PMID: 14973409 Review.
Cited by
-
Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts.JHEP Rep. 2023 Jun 29;5(10):100835. doi: 10.1016/j.jhepr.2023.100835. eCollection 2023 Oct. JHEP Rep. 2023. PMID: 37771547 Free PMC article. Review.
-
The PCOS-NAFLD Multidisease Phenotype Occurred in Medaka Fish Four Generations after the Removal of Bisphenol A Exposure.Environ Sci Technol. 2023 Aug 29;57(34):12602-12619. doi: 10.1021/acs.est.3c01922. Epub 2023 Aug 15. Environ Sci Technol. 2023. PMID: 37581432 Free PMC article.
-
The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.Metabolites. 2023 Jan 14;13(1):129. doi: 10.3390/metabo13010129. Metabolites. 2023. PMID: 36677054 Free PMC article. Review.
-
Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones.Front Endocrinol (Lausanne). 2022 Nov 7;13:1032361. doi: 10.3389/fendo.2022.1032361. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36419770 Free PMC article.
-
NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features.Biomedicines. 2022 Oct 27;10(11):2719. doi: 10.3390/biomedicines10112719. Biomedicines. 2022. PMID: 36359239 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous